| Issue Date | Title | Author(s) |
| 2020 | Anticancer and antimetastatic activity of Hypomyces chrysospermus, a cosmopolitan parasite in different human cancer cells | Dikmen, M.; Öztürk, Selin Engür ; Cantürk, Z.; Ceylan, G.; Karaduman, A.B.; Yamaç, M. |
| 2024 | Anticarcinogenic activity of Cl-Amidine on non-small cell lung cancer | Öğüten, P.N.; Engür, Öztürk, S. ; Di̇Kmen, M. |
| 2022 | Comparative Analysis of Antioxidant and Anticancer Activities of Fruiting Bodies, Mycelial Biomass and Culture Liquid of Omphalotus olearius OBCC 2503 (Agaricomycetes) from Turkey | Yamac, Mustafa; Ozturk, Selin Engur ; Canturk, Zerrin; Dikmen, Miris |
| 2021 | Comparison of the apoptotic effects of bortezomib using 2D and 3D co-culture models of THP-1 derived macrophage and A549 lung cancer | Ozturk, Selin Engur ; Tilki, Elif Kaya; Dikmen, Miris; Canturk, Zerrin |
| 2024 | Enhanced angiogenesis of human umbilical vein endothelial cells via THP-1-derived M2c-like macrophages and treatment with proteasome inhibitors 'bortezomib and ixazomib' | Engür-Özturk, Selin ; Kaya-Tilki, Elif; Cantürk, Zerrin; Dikmen, Miris |
| 2024 | The investigation of cytotoxic and apoptotic activity of Cl-amidine on the human U-87 MG glioma cell line | Öǧüten, P.N.; Engür, Öztürk, S. ; Dikmen, M. |
| 2021 | Investigation of the neuroprotective and neuritogenic effects of halotolerant Penicillium flavigenum-derived sorbicillin-like compounds on PC-12 Adh cells | Kaya Tilki, Elif; Engur ozturk, Selin ; Ozarda, Mustafa Guclu; Canturk, Zerrin; Dikmen, Miris |
| 2023 | Pro-inflammatory 'M1 macrophage' vs anti-inflammatory 'Hydrocortisone' a new approach to wound healing in HaCaT cells | Engür Öztürk, Selin |
| 2022 | Proteasome inhibitor immunotherapy for the epithelial to mesenchymal transition: assessing the A549 lung cancer cell microenvironment and the role of M1, M2a and M2c 'hydrocortisone-polarised' macrophages | Engur-Ozturk, Selin ; Dikmen, Miris |
| 2021 | Targeting epigenetic chromatin modification enzymes upregulated by M2c macrophage polarization with a proteasome inhibitor ixazomib in lung cancer: a novel approach | Tilki, Elif Kaya; Ozturk, Selin Engur |
